130 related articles for article (PubMed ID: 20621714)
1. The creation of the Comparative Oncology Trials Consortium Pharmacodynamic Core: Infrastructure for a virtual laboratory.
Paoloni M; Lana S; Thamm D; Mazcko C; Withrow S
Vet J; 2010 Jul; 185(1):88-9. PubMed ID: 20621714
[TBL] [Abstract][Full Text] [Related]
2. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
3. Cancer and comparative imaging.
LeBlanc AK
ILAR J; 2014; 55(1):164-8. PubMed ID: 24936036
[TBL] [Abstract][Full Text] [Related]
4. Cancer researchers usher in dog days of medicine.
Mack GS
Nat Med; 2005 Oct; 11(10):1018. PubMed ID: 16211022
[No Abstract] [Full Text] [Related]
5. The role of clinical trials in veterinary oncology.
Burton J; Khanna C
Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):977-87. PubMed ID: 25174911
[TBL] [Abstract][Full Text] [Related]
6. The development of phase I cancer trial methodologies: the use of pharmacokinetic and pharmacodynamic end points sets the scene for phase 0 cancer clinical trials.
Calvert AH; Plummer R
Clin Cancer Res; 2008 Jun; 14(12):3664-9. PubMed ID: 18559580
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic biomarkers for molecular cancer therapeutics.
Sarker D; Workman P
Adv Cancer Res; 2007; 96():213-68. PubMed ID: 17161682
[TBL] [Abstract][Full Text] [Related]
8. Clinical trials going to the dogs: canine program to study tumor treatment, biology.
Mack GS
J Natl Cancer Inst; 2006 Feb; 98(3):161-2. PubMed ID: 16449674
[No Abstract] [Full Text] [Related]
9. Fighting cancer in dogs. Morris Animal Foundation leads campaign to find cures.
Rezendes A
J Am Vet Med Assoc; 2007 May; 230(9):1287-8. PubMed ID: 17489135
[No Abstract] [Full Text] [Related]
10. [Chemotherapy discussion].
van den Heuvel W; van der Wijden M; Spiekermann S
Tijdschr Diergeneeskd; 2004 Jun; 129(11):382. PubMed ID: 15211910
[No Abstract] [Full Text] [Related]
11. The Comparative Oncology Trials Consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway.
Gordon I; Paoloni M; Mazcko C; Khanna C
PLoS Med; 2009 Oct; 6(10):e1000161. PubMed ID: 19823573
[TBL] [Abstract][Full Text] [Related]
12. Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice.
Kinders R; Parchment RE; Ji J; Kummar S; Murgo AJ; Gutierrez M; Collins J; Rubinstein L; Pickeral O; Steinberg SM; Yang S; Hollingshead M; Chen A; Helman L; Wiltrout R; Simpson M; Tomaszewski JE; Doroshow JH
Mol Interv; 2007 Dec; 7(6):325-34. PubMed ID: 18199854
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. New science-based endpoints to accelerate oncology drug development.
Kelloff GJ; Sigman CC
Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
[TBL] [Abstract][Full Text] [Related]
15. Species differences in tumour responses to cancer chemotherapy.
Lawrence J; Cameron D; Argyle D
Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1673):. PubMed ID: 26056373
[TBL] [Abstract][Full Text] [Related]
16. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy of tumors in dogs].
Austie BA; Rutteman GR; Misdorp W
Tijdschr Diergeneeskd; 1988 Mar; 113(6):299-310. PubMed ID: 3283998
[TBL] [Abstract][Full Text] [Related]
18. Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature.
Paoloni MC; Tandle A; Mazcko C; Hanna E; Kachala S; Leblanc A; Newman S; Vail D; Henry C; Thamm D; Sorenmo K; Hajitou A; Pasqualini R; Arap W; Khanna C; Libutti SK
PLoS One; 2009; 4(3):e4972. PubMed ID: 19330034
[TBL] [Abstract][Full Text] [Related]
19. Cancer clinical trials: development and implementation.
Vail DM
Vet Clin North Am Small Anim Pract; 2007 Nov; 37(6):1033-57; v. PubMed ID: 17950881
[TBL] [Abstract][Full Text] [Related]
20. Perils and pitfalls of clinical trials--experience from human oncology.
Pitson G; Fyles A
J Vet Intern Med; 2000; 14(4):392-4. PubMed ID: 10935888
[No Abstract] [Full Text] [Related]
[Next] [New Search]